DOW-UAP-D119 — AAWSAP DIRD, Biomaterials, January 2010
File DOW-UAP-D119 is a declassified pdf from Department of War, recording an incident dated 1/7/10 at Las Vegas, Nevada, published in Release 06 (2026-09-18). This page carries the original file, its official summary and its full text.
- File
- DOW-UAP-D119
- Agency
- Department of War
- Incident date
- 1/7/10
- Location
- Las Vegas, Nevada
- Released in
- Release 06 (2026-09-18)
- File type
Topics: AAWSAP & DIRDs
This document is a Defense Intelligence Reference Document (DIRD), a technical reference format used by the Defense Intelligence Agency (DIA) to capture baseline knowledge on a specific topic for later analytic use. DIRDs are best understood as reference and synthesis products rather than as original research. It is one of 38 DIRDs produced under the Advanced Aerospace Weapon System Applications Program (AAWSAP) between 2009 and 2011. Because AAWSAP’s scope permitted a broad range of supporting topics, not every DIRD in the series directly concerns aerospace systems or future threat assessment. The following summary reflects the DIRD’s scope and framing at the time of writing and should not be read as implying current validation of the concepts discussed.
This DIRD is a broad survey of biomaterials, including metals, polymers, ceramics, glasses, and composites designed to interact with living tissue, and argues that their value depends mainly on biocompatibility, reliability, and careful matching of material properties to specific medical uses. The report reviews major application areas including biosensors, implants, cardiovascular devices, contact lenses, drug delivery systems, tissue constructs, titanium devices, and dialysis membranes, emphasizing that no single biomaterial works best in every setting. Its overall conclusion is that biomaterials are already foundational to a large medical-device industry and save or improve millions of lives, but that progress tends to be slow because safety testing is stringent; as a result, most advances come from improved ways of applying established materials such as silicone, Teflon, biodegradable polymers, ceramics, and titanium in new devices and clinical settings rather than from radically new substances.
Open original file · WAR.GOV page
TL;DR
January 2010: when even the biomaterials were still getting New Year's resolutions.
- DIRD DOW-UAP-D119, DoW, Jan 2010, Las Vegas, NV.
- Surveys biomaterials—metals, polymers, ceramics, composites—for implants, sensors, drug delivery, etc.
- Concludes biomaterials already essential to medical devices; advances are incremental, not radical.
AI summary
A classified document titled "Biomaterials" prepared by the Defense Intelligence Agency's Acquisition Support Division in January 2010 outlines the use of biomaterials in medical devices. It describes materials such as silicones, Teflon, biodegradable polymers, titanium, and ceramics, focusing on their chemical structures, properties, and biomedical applications. The document covers implants, biosensors, diagnostic tools, and devices like dialyzers, stents, and vascular grafts. It discusses biocompatibility, drug delivery, tissue engineering, and specific applications including sutures, heart valves, and contact lenses. The text includes technical details about materials used in blood-contacting applications and their interactions with biological systems.
Full text
Page 2
UNCLASSIFIED/ /POR OPP!CU%L "9~ OHL I
Biomaterials
Prepared by:
Acquisition Support Division (DW0-3)
Defense Warning Office
Directorate for Analysis
Defense Intelligence Agency
Author:
AAP Person 65
Administrative Note
COPYRIGHT WARNING: Further dissemination of the photographs in this publication is not authorized.
This product is one in a series of advanced technology reports produced in FY 2009
under the Defense Intelligence Agency, Defense Warning Office's Advanced Aerospace
Weapon System Applications (AAWSA Pro ram. Comments or uestions pertaining to
AAWSA Program
this document should be addressed t AAP Person 1
Manager, Defense Intelligence Agency, ATTN: CLAR/DWO-3, Bldg 6000, Washington,
DC 20340-5100.
iii
UNCLASSIFIED//FOR OEFICI0L W&li &Ht¥
Page 3
UNCLASSIFIED/ /POR. orr1e1J1tt tl.!I!!! OHLV
Contents
Introduction ...........................................................................................................vi
Importance of Biocompatibility .........................................................................vii
Science of Bio materials .....................................................................................vii
Biomaterials for Biosensors ................................................................................... 1
Biomaterials for Biomedicine ................................................................................. 2
Biomedical Silicones - Polydimethylsiloxanes .................................................... 2
Silicone Chemistry.............................................................................................. 4
Silicone in Biomedical Products .......................................................................... 4
Teflon ................................................................................................................. 6
Biodegradable Polymers ..................................................................................... 7
Biodegradation Advantages ............................................................................... 8
Degradable Biomaterials .................................................................................... 8
Polylactic Acid and Polyglycolic Acid .................................................................. 8
Polyethylene Glycol or Polyethylene Oxide ....................................................... 10
Hydrogels ......................................................................................................... 10
Titanium - Hip and Knee Joints ........................................................................ 11
BioCeramics ..................................................................................................... 11
Dental Ceramics ............................................................................................... 13
Tissue Constructs as Biomaterials ...................................................................... 13
Cardiovascular Biomaterials ............................................................................. 15
Stent Biomaterials............................................................................................ 18
Nitinol as a Biomaterial .................................................................................... 19
Contact Lenses ................................................................................................. 19
Drug Delivery Polymers .................................................................................... 20
Medical Titanium as a Biomaterial .................................................................... 22
iv
UNCLASSIFIED//50B OFFICIO ls. U&'li QPlls.¥
Page 4
UNCLASSIFIED/ /fQR &FFIEJIAL YSI!! 8HL'f
Biomaterials in Dialysis .................................................................................... 24
Summary and Recommendations ......................................................................... 25
Figures
Figure 1. Biomaterial Applications in Medical Devices ............................................vi
Figure 2. Common Medical Devices That Use Biomaterials ................................... viii
Figure 3. Biomaterials Such as Polycarbonates, Cellulose, and Silicones Used in
Membranes for Sensors, Dialyzers, and Oxygenators .............................. 1
Figure 4. Photograph of Silicone (polydimethyllsiloxane) Biomedical Implants
Used in Breast Reconstructive Surgery ................................................... 3
Figure 5. Silicone Chemical Groups ........................................................................ 4
Figure 6. Silicone Tracheostomy Tube .................................................................... 5
Figure 7. Silicone Sheets Used Under the Skin as a Physical Supporting Layer for
Repair of Scar Tissue ............................................................................... 5
Figure 8. Teflon Structure ...................................................................................... 6
Figure 9. Expanded PTFE (Gore-Tex or ePTFE) Used in Lip Implants ...................... 7
Figure 10. Biodegradable Polymers ........................................................................ 7
Figure 11. Structure of Polylactic Acid (a Biodegradable Polymer) ........................ 9
Figure 12. Biodegradable PLA as an Antiadhesion Barrier after Open-Heart
Surgery ................................................................................................. 9
Figure 13. Biodegradable Polymers Based on Copolymers of Polylactic Acid and
Polyethylene Glycol (Polysciences Inc) ............................................... 10
Figure 14. Dots of Hydrogel .................................................................................. 10
Figure 15. Various Titanium Components Used in Hip Joint Replacement ............ 11
Figure 16. Hydroxyapatite Porous Bone-Like Structure After Commercial
Processing .......................................................................................... 12
Figure 17. Bioceramic Used in Artificial Hip Replacement Component .................. 12
Figure 18. Computer-Based Sculpted Ceramic Teeth ............................................ 13
Figure 19. Scaffold-Guided Tissue Regeneration .................................................. 14
Figure 20. Biodegradable Material CSLG Deposited in a Honeycomb Structure to
Allow Infiltration by Living Cells While in a Submerged Cell Culture ... 15
Figure 21. Some of the More Popular Biomedical Devices and Duration of Their
Blood Contact ...................................................................................... 16
Figure 22. Gore Medical Teflon Foam Used in Vascular Grafts .............................. 16
Figure 23. Illustration of Treatment of an Atrial Septal Defect Using a
Teflon-Based Product Manufactured by Gore, Inc............................... 17
Figure 24. Stainless Steel and Teflon Bjork Shiley Heart Valve ............................ 18
Figure 25. Illustration of Stent Placement ........................................................... 18
Figure 26. Nitinol Stent ........................................................................................ 19
Figure 27. Contact Lens........................................................................................ 20
Figure 28. Schematic Representation of Biodegradable (Bioerodible) Drug
Delivery Device ................................................................................... 21
Figure 29. Photomicrograph of Titanium Metal (Appears Black in This Photo)
in an Intimate Integration With Living Bone ....................................... 23
Figure 30. Illustration (Left) and Photograph (Right) of a Blood Dialyzer as
Used in Medicine ................................................................................. 24
Figure 31. Cuprophane Membrane Passes Blood Waste Products (Violet and
Orange Dots) Through Pores and Blocks Passage of Red Blood Cells .. 25
V
UNCLASSIFIED/ /f81l err1e1J1ct U:!I!! eHt f
Page 5
UNCLASSIFIED/ /POR. orr1e1J1tt tl.!I!!! OHLY
Biomaterials
Introduction
Biomaterials are metals, ceramics, polymers, glasses, carbons, and composite
materials intended to interface with biological systems. They are often used to
treat, augment, or replace bodily tissues, organs, or functions. Such materials
are used in various forms, including molded or machined parts, coatings,
fibers, films, foams, and fabrics. Biomaterials are usually nonliving, but recent
definitions also include living skin and tissues produced in culture.
A biocompatible material is different from a biological material produced by a
biological system, such as bone. Artificial hips, vascular stents, artificial
pacemakers, and catheters are all made of biocompatible materials that
typically have a synthetic origin. An extraordinarily wide range of medical
devices are made from biomaterials. Figure 1 shows some representative
examples of medical devices that use biomaterials.
Finger joint
Breast implant
Heart valve
.lloooe rubber
Hip j int
tifi ial heart
poly\lr
Figure 1. Biomaterial Applications in Medical Devices
Encompassing elements of medicine, biology, chemistry, and materials science,
biomaterials science has experienced steady and strong growth over its
approximately half-century history.
Although biomaterials are used primarily for medical applications, they are
also used to grow cells in culture, to assay for blood proteins in the clinical
vi
UNCLASSIFIED/ /FOR OFFICIAL USE ONLY
Page 6
UNCLASSIFIED// FOR OFFICl"L l:191!!! 9HLY
laboratory, in processing biomolecules in biotechnology, for fertility regulation
implants in cattle, in diagnostic gene arrays, in the aquaculture of oysters, and
for investigational cell-silicon "biochips." The common thread in these
applications is the interaction between biological systems and synthetic or
modified natural materials.
Biomimetic materials, in contrast, are not made by living organisms but have
compositions and properties similar to materials made by living organisms.
For example, the calcium hydroxyapatite coating found on many artificial
hips-used as metal-bone interface cement to make it easier to attach
implants to bone-is similar to the coating found in mollusk shells.
IMPORTANCE OF BIOCOMPATIBILITY
Biocompatibility is an important issue in biomedical implants and sensors. A
material-tissue interaction that results from implanting a foreign object in the
body is a major obstacle to developing stable and long-term implantable
devices and sensors.
The processes that occur when sensors are placed in the complex living
environment of the human body are sometimes known as biofouling. In
biofouling, the physical or chemically sensitive portion of the sensor interface
becomes coated with proteins, blood-formed elements, adherent
immunological cells, and sometimes forms of scar tissue that tend to isolate
the sensor from the rest of the body environment. This response of tissue is a
foreign body reaction to any object introduced in tissue that does not express
surface characteristics that identify it as part of the host tissues.
Experiences of many investigators (more than 600 reported studies since 1996)
with the biocompatibility of biomaterials related to the function of implanted
biosensors have been poor such that many companies have abandoned
implantable sensor devices altogether. Rather, the recent trend in medical
biosensors is toward placing them outside the body. Newer sensors are often
based on optical principles in an effort to obviate the biocompatibility and
biomaterial issues of placing sensors inside the human body.
SCIENCE OF BIOMATERIALS
The study and use of biomaterials bring together researchers from diverse
academic backgrounds who must communicate clearly. Professions that
intersect in the development, study, and application of biomaterials include
bioengineer, chemist, chemical engineer, electrical engineer, mechanical
engineer, materials scientist, biologist, microbiologist, physician, veterinarian,
ethicist, nurse, lawyer, regulatory specialist, and venture capitalist.
The number of medical devices used each year in humans is very large. Figure
2 estimates usage for common devices, all of which employ biomaterials.
vii
UNCLASSIFIED/ /FOlil OFFICiI>~ U&ili Qt11 X
Page 7
UNCLASSIFIED// POI\ OPPICl"L U.!E! Oflt (
Numbers of Medical Devices/yr. Worldwi,.,..... - intraocular lens
contact lens
vascular graft
hip and knee prostheses
catheter
heart valve
stent (cardiovascular)
breast implant
dental implant
pacemaker
renal d ialyzer
left ventricular assist devices
7,000,
75,000,000
400,000
1,000,000
300,000,000
200,000
>2,000,000
300,000
500,000
200,000
25,000,000
100,000
Millions of lives saved. The quality of Life improved for millions more.
A $100 billion industry
Figure 2. Common Medical Devices That Use Biomaterials
The development of biomaterials is the junction of materials science and
chemistry. Medical devices may be composed of a single biomaterial or a
combination of several materials. A heart valve might be fabricated from
polymers, metals, and carbons. A hip joint might be fabricated from metals
and polymers (and sometimes ceramics) and will be interfaced to the body
through a polymeric bone cement.
Biomaterials by themselves do not make a useful clinical therapy but rather
have to be fabricated into devices. This is typically an engineer's role, but the
engineer might work closely with synthetic chemists to optimize material
properties and with physicians to ensure the device is useful in clinical
applications.
Biomaterials must be compatible with the body, and there are often issues
that must be resolved before a product can be placed on the market and used
in a clinical setting. Because of this, biomaterials are usually subjected to the
same very stringent safety requirements as those of new drug therapies.
viii
UNCLASSIFIED/ ,,roA &FFI@IAL U:!E: Oflt I
Page 8
UNCLASSIFIED/ /FOR OFFICIAL USE Oiltt
Biomaterials for Biosensors
Implantable biosensors for the human body place some of the greatest functional
demands on biomaterials. Biosensors monitor the physiologic state of tissues for
medical therapeutics or for assessing human performance. Sensors for glucose, oxygen,
blood pH, adrenal hormones, nervous activity, heart performance, and blood pressure
monitors are all of interest.
Blood biochemistry sensors are the most difficult sensors to keep functioning over time
primarily because the sensor interface materials provoke low-level foreign-body
reactions in t issues. These types of responses are not specifically important to
implantable devices that have structural rather than sensing functions, such as heart
valves, but they can completely render a biosensor for blood glucose, for example,
useless after a few days.
Chemically sensitive biosensor interfaces to tissue and body environments employ
membranes in an effort to protect the biosensor active-sensing surface from possible
body reactions. The membrane allows small molecules of interest to pass through its
pores while excluding larger proteins, blood-formed elements, and cells like
macrophages that would engulf the sensor.
The membrane's biomaterial composition, pore size, and long-term physical integrity
are critical components in the functioning of the sensor. If the biomaterial chosen
retards the adhesion of proteins and does not provoke a biological response, then this
improves sensor longevity. Figure 3 shows some representative biomembranes.
No one biomaterial is best for all
sensor applications, primarily because
different biomaterials behave
differently relative to the substance
being sensed. Membranes that pass
glucose, for example, may not pass
oxygen that is needed for a sensor to
function. Membrane biofouling starts
immediately upon contact of the
sensor with the body cells. Proteins
and other biological components
adhere to the sensor surface, and in
some cases, impregnate the pores of
the material. This process retards
diffusion of the molecules of interest
to the sensor surface and either slows
the sensor's response to changes in
concentration or reduces the overall
response to the point where the
sensor falls out of calibration.
Figure 3. Biomaterials Such as Polycarbonates,
Cellulose, and Silicones Used in Membranes for
Sensors, Dialyzers, and Oxygenators
The design of sensor membrane materials has been found to be critically dependent on
subtle features of the membrane's chemistry, material thickness, and porosity, as well
as, more generally, where in the human body the sensor is located. The blood stream is
1
UNCLASSIFIED/ /fiiOA OFFI&IAk WSE 8rtt'f
Page 9
UNCLASSIFIED/ /FOA OFFI€1Ak Ulilii ONkY
the most hostile location both for sensor performance and in terms of the potential for
danger to the patient through the provocation of blood clotting.
The most successful biomembrane materials have been porous forms of Teflon,
polyurethanes, and cellulose-based materials such as cellulose acetate. As important as
the material composition is for sensors, so are aspects of a membrane's structure and
mechanical properties, such as its ability resist abrasion and adhere to sensor surfaces.
Biomaterials for Biomedicine
In this review, we look at representative biomaterials as well as representative
applications. These biomaterials are among the most popular of t hose used in medicine
today, and the applications in some cases represent multibillion-dollar-a-year markets.
Some of the best known of the biomaterials are:
•
Silicone
•
Teflon
•
Biodegradable polymers
•
Hydrogels
•
Titanium alloys
•
Ceramics
•
Tissue constructs
Some of the largest applications are:
•
Cardiovascular - stents, synthetic blood vessels, heart valves
•
Hip and knee joints
•
Contact lenses
•
Drug delivery devices
•
Kidney dialysis
BIOMEDICAL SILICONES- POLYDIMETHYLSILOXANES
Perhaps the most well known of all biomaterials are the silicones-soft, pliable, and
semitransparent materials that are used in many different applications in modern
society, ranging from water sealants to fibrous insulations.
Silicone is often mistakenly called "silicon." Although sil icones contain silicon atoms,
they are an organic material of greater complexity and are not made up exclusively of
silicon. Silicone is used in an exceptionally large number of biomedical applications. It is
blood compatible, sterilizable, rugged, and strong but flexible. Its mechanical properties
2
UNCLASSIFIED/ /EOR OFFICilAk W&li 8HLY
Page 10
UNCLASSIFIED/ /FOA OFFl&IAk 1481!! 8HL'f
can be tailored to varying degrees of hardness and strength for stiffness in catheter
applications.
Biomed ical silicones attracted notoriety in 1995 when a class-action lawsuit against
Dow Corning, Inc., brought a huge settlement resulting from the supposed dangers of
silicone breast im plants.
After reviewing years of evidence and research concerning silicone gel-filled breast
implants, the national Institute of Medicine found that "evidence suggests diseases or
conditions such as connective tissue diseases, cancer, neurological diseases or other
systemic complaints or conditions are no more common in women with breast implants
than in women without implants." Dow moved out of the medical silicone business and
has since been replaced by an array of smaller companies offering specialized silicone
products.
Figure 4 shows the present form of silicone used for reconstructive surgery following a
mastectomy, particu larly after breast cancer in women.
Figure 4. Photograph of Silicone (polydimethyllsiloxane) Biomedical Implants Used in Breast
Reconstructive Surgery
3
UNCLASSIFIED/ fFOlil OFFIQIAk Uiili 0PIL¥
Page 11
UNCLASSIFIED/ ;'FOR OFFI@IAL YSE OHL¥
SILICONE CHEMISTRY
Silicone is actually a common name
for the chemical compound
polydimethylsiloxane (PDMS), a class
of synthetic polymers with repeating
units of silicon and oxygen. Figure 5
shows the polymeric repeating
structure of medical silicones. Various
functional groups-often methyl-can
be attached to that backbone to
change the material properties.
Silicone polymers can easily be
transformed into linear or cross
linking materials without using any
toxic plasticizers . The resulting
materials are elastic at body
temperature.
The simultaneous presence of
Figures. Silicone Chemical Groups
different groups attached to the
silicon-oxygen backbone gives silicones a range of viscous and mechanical properties
that allow their use as fluids, emulsions, compounds, resins, and elastomers in
numerous applications. Thus, silicone is a versatile polymer, although its use is often
limited by its relatively poor mechanical strength. However, this limitation can be
overcome by reinforcing silicone with a silica filler or by chemically modifying the
backbone.
The stability, lack of toxicity, and excellent biocompatibility of PDMS make these
materials well suited for use in personal care, pharmaceutical, and medical device
applications. Silicone is easily molded and cast using room temperat ure curing (known
as RTV) or through the use of an organic catalyst.
SILICONE IN BIOMEDICAL PRODUCTS
Silicone membranes are made by casting the silicone liquid precursor into thin sheets.
Such membranes are often used in oxygen and carbon dioxide blood biosensors
because membranes made of this material are highly transmissive to these gases while
they block most other chemical substances present in the blood stream. In addition,
silicone's resistance to protein adhesion and its excellent overall biocompatibility make
it one of the most commonly used materials for encapsulating biosensors for tissue or
blood contact.
Recent formu lations of silicone can be patterned with ultraviolet light and, thus, lend
themselves to manufacture with biosensors made by photolithography.
4
UNCLASSIFIED/ /EOR OFFICilAk YSE 8HLY
Page 12
UNCLASSIFIED// re1t Offl@IAL lel&li 9PUElf
Figure 6. Silicone Tracheostomy Tube
Figure 6 is a representative example of silicone-based medical products involving tubes
or catheters. A tracheostomy tube, or "trach tube," is a 2- to 3-inch-long curved metal
or plastic tube placed in a surgically created opening (tracheostomy) in the windpipe to
keep it open. Versions of these products are used in cases where patients have
difficulty breathing on their own, such as in a spinal cord injury.
A product known as Mepiform™ is an example of silicone use in a sheet form for the
management of scars, particularly keloid scars. Figure 7 shows this product.
Figure 7. Silicone Sheets Used Under the Skin as a Physical Supporting Layer for Repair of Scar Tissue
5
UNCLASSIFIED/ /EOA OliEIClt.L: Uii QPUalf
Page 13
UNCLASSIFIED/ /FOR OFFI@IAL YSE OHL¥
TEFLON
Biomedical materials must be inert to the complex chemistry of biological fluids so they
neither suffer nor instigate change in tissue. Teflon™ admirably fulfills these
requirements. Teflon is a trade name for polytetrafluoroethylene (PTFE), a
fluorocarbon-based polymer. It is made by free radical polymerization of
tetrafluoroethylene and has a carbon backbone chain in which each carbon has two
fluorine atoms attached to it.
This polymer is hydrophobic (water hating), biologically inert, and nonbiodegradable
and also has low friction characteristics and excellent "slipperiness." The chemical
inertness (stability) of PTFE is re lated to the strength of the fluorine-carbon bond that
makes it resistant to adhesion. Figure 8 shows the structure of this material. It is a long
chain of repeating chemical units, as shown in the right of the figure.
Figure 8. Teflon Structure
Goretex® is a medical form of Teflon (PTFE) that, when stretched and extruded,
entraps air cells in its microstructure much like foam does and, thus, is relatively soft
and repellant to most liquids. This material is known as e-PTFE (expanded PTFE).
PTFE can be fabricated in many forms, including pastes, tubes, strands, and sheets,
while ePTFE can be woven into a porous, fabric-like mesh. When implanted in the body,
th is strong mesh allows tissue to grow into its pores, making it ideal for medical devices
such as vascular grafts.
6
UNCLASSIFIED/ {EAR OFFICIO 1 1Pili QPlk¥
Page 14
UNCLASSIFIED/ /FOR. errl@IAL YSI: e .. tv
Preformed ePTFE subcutaneous
implant materials have been used to
improve facial reconstruction and
cosmetic surgery outcomes. Figure 9
is a manufacturer's product
information showing the utility of
using ePTFE in cosmetic surgery.
BEFORE
AFrER
PTFE has relatively low wear
BEFORE
AFrER
resistance, but under compression or
in situations where rubbing or
abrasion can occur, it can produce
wear particles. These can result in a
chronic inflammatory reaction, an
undesirable outcome. For a given
application, the biomateria ls engineer
must consider many aspects of the
Figure 9. Expanded PTFE (Gore-Tex or ePTFE) Used in
physical and biological properties of
Lip Implants. This is a synthetic implant that has been
the materials . Thus, although PTFE is
used in the face and body for many years. The main
advantage is that it is not absorbed over time and the
highly inert in the body, applying it in
results are permanent .
the wrong circumstances (for
example, to a device that is under
compression or exposed to wear) may lead to a reaction that no longer qualifies as
"biocompatible."
BIODEGRADABLE POLYMERS
Biodegradable polymers are an
important and relatively large
category of biomaterials that are used
extensively in the medical and food
industries. In the latter, they are used
as food wrappings and other
packaging derived from natural food
substances that slowly degrade-by
evaporation into water vapor and
carbon dioxide- when exposed to the
sun and outdoor environments, thus
minimizing waste disposal. Figure 10
shows a complex shape made from
polylactide (PLA), a biodegradable
polymer.
Biodegradable polymers can be either
Figure 10. Biodegradable Polymers. Polymers such as
PLA are much like conventional plastics and, as such , have
natural or synthetic. In general,
qualities of clarity, flexibility, and strength.
synthetic polymers offer greater
advantages than do natural materials in that they can be tailored to give a wider range
of properties and more predictable lot-to-lot uniformity than can materials from natural
sources . Synthetic polymers also represent a more reliable source of raw materials-
7
UNCLASSIFIED/ {FOR OEE!CJA1 11SE QNI X
Page 15
UNCLASSIFIED// FOR 8FFl@IAk Uili ON! X
one free from concerns of immunogenicity . These polymers can be optically clear,
exhibit good flexibility, and have strength comparable to that of many plastics.
BIODEGRADATION ADVANTAGES
In the human body, biodegradable polymers have good compatibility but also
decompose to harmless materials and over time dissolve altogether. Biodegradable
polymers undergo a chemical hydrolysis in the salty and wet environment of tissues by
way of a labile chemical backbone of the polymer. The degradation starts immediately
upon water exposure and occurs in two steps.
In the first step, the material t horoughly hydrates, and the water attacks the polymer
chains, converting long chains into shorter, water-soluble fragments. The desirable
aspect of this process is a reduction in molecular weight without a loss in physical
properties, since the device matrix is still held together, even with the shorter chains.
In the second step, the shorter polymer chains are attacked by enzymes that are
naturally present in tissues. Basically, a metabolization of the fragments by the body
tissues results in a rapid loss of polymer mass, what is referred to as bulk erosion. All
the commercially available synthetic devices and sutures degrade by bulk erosion.
DEGRADABLE BIOMATERIALS
Different biodegradable polymers have different lifetimes in tissues, ranging from a few
days to years . Combining two different biopolymers-for example, short-lived (days)
PLA (polylactide) and longer lived (months) PGA (polyglycolide)-reveals that polymers
can be produced with intermediate decomposition times. Thus, their decay times can be
custom determined through their formulation.
Biodegradable polymers fulfill a physician's desire to have an implanted device that will
not require a second surgical intervention for removal, which is desirable in many
applications. In orthopedic applications, for example, a fractured bone that has been
fixated with a rigid, nonbiodegradable stainless implant has a tendency for refracture
upon removal of the implant, making removal undesirable. This refracturing results
from the offloading of the stress on the bone by the stainless steel support because the
bone has not carried a sufficient load during the healing process. However, a fixation
system prepared from a biodegradable polymer can be engineered to degrade at a rate
that will slowly transfer the load to the healing bone, thereby avoiding the risk of
refracture and eliminating the need to remove the impla nt.
POLYLACTIC ACID AND POLYGLYCOLIC ACID
Polylactic acid (PLA), polyglycolic acid (PGA), and their copolymers are the most widely
used of the biodegradable polymers. These materials, when exposed to the sun and
weather, will degrade into water and carbon dioxide and essentially vanish, given
sufficient time.
In the human body, combinations of PLA and PGA are used to control the longevity of a
material by controlling its degradation rate when exposed to tissues. The degradation
products in the human body are also water and carbon dioxide.
8
UNCLASSIFIED//EOR OSSICIAk WSE 8HL'I
Page 16
UNCLASSIFIED// FOR OFFICIAL t:191!! 9HL\I
PLA, or polylactide, is a thermoplastic,
long-chained organic material derived
from renewable resources, such as
corn starch (in the United States) or
sugarcanes (in the rest of the world).
PLA has been recognized for more
than a century and is of commercial
interest primarily because of its
biomedical applications. Figure 11
shows the chemical structure of PLA.
These materials are popular because
they have already been used in many
approved medical implant devices and
Previous: DOW-UAP-D118 — AAWSAP DIRD, Aerospace Applications of Programmable Matter, December 2009 · Next: DOW-UAP-D120 — AAWSAP DIRD, Materials for Advanced Aerospace Platforms, January 2010
Same topic: title & summary match
Same location: Las Vegas, Nevada
- DOW-UAP-D174 — Utah Ranch Investigation Report, April 2010
- DOW-UAP-D166 — MUFON Reports Prepared for BAASS, November 2008
- DOW-UAP-D168 — BAASS Project Management Plan, December 2008
- DOW-UAP-D169 — BAASS Monthly Report, March 2009
- DOW-UAP-D170 — BAASS Monthly Report, April 2009
- DOW-UAP-D171 — BAASS Monthly Report, June 2009
Same period: 2010
- DOW-UAP-D114 — AAWSAP Contract Modification P00003, May 2010
- DOW-UAP-D113 — AAWSAP Contract Modification P00002, February 2010
- DOW-UAP-D115 — AAWSAP Contract Modification P00004, May 2010
- DOW-UAP-D116 — AAWSAP Contract Modification P00005, September 2010
- DOW-UAP-D133 — AAWSAP DIRD, The Space Communication Implications of Quantum Entanglement and Nonlocality, March 2010
- DOW-UAP-D134 — AAWSAP DIRD, Maverick Inventor Versus Corporate Inventor: Where Will the Next Major Innovations Arise, March 2010
Same release: Release 06
- DOW-UAP-PR159 — Historical Film of Reported UFOs, Utah, 1952
- LLE-UAP-PR001 — Unresolved UAP Report, Colorado, 2023
- LLE-UAP-PR002 — Unresolved UAP Report, Colorado, October 2023
- DOW-UAP-PR133 — Unresolved UAP Report, Middle East, 2025
- DOW-UAP-PR135 — Unresolved UAP Report, Middle East, 2025
- DOW-UAP-PR140 — Unresolved UAP Report, Middle East, 2022
Same agency: DoW
- DOW-UAP-D094 — Analysis of Flying Object Incidents in the United States, 1949
- DOW-UAP-D097 — Project Sign Progress Report, 1948
- DOW-UAP-D084 — US Army-Flying-Saucer-Study 1949
- DOW-UAP-D155 — Air Intelligence Information Report, Saudi Arabia, 1957
- DOW-UAP-D176 — Triangular UAP AARO Memorandum for Record, 2026
- DOW-UAP-D177 — Unresolved UAP Report, Catalina Island, 1955